These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6298865)

  • 1. Dopamine neurotransmission and brain function.
    Ungerstedt U; Herrera-Marschitz M; Zetterström T
    Prog Brain Res; 1982; 55():41-9. PubMed ID: 6298865
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thoughts on the neurobiological aspects of Parkinson syndrome].
    Sommer H
    Psychiatr Neurol Med Psychol (Leipz); 1986 Feb; 38(2):86-90. PubMed ID: 3010357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiology of the normal and dopamine-depleted basal ganglia: insights into levodopa pharmacotherapy.
    Grace AA
    Mov Disord; 2008; 23 Suppl 3():S560-9. PubMed ID: 18781673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current perspectives in the treatment of Parkinson disease].
    Rodríguez M; Palarea MD; Castro R; Pérez J; Arévalo R
    Med Clin (Barc); 1985 Nov; 85(15):633-40. PubMed ID: 2867259
    [No Abstract]   [Full Text] [Related]  

  • 5. Parkinson's disease. The L-dopa era.
    Yahr MD
    Adv Neurol; 1993; 60():11-7. PubMed ID: 8420128
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacotherapy of Parkinson's disease.
    Cohen MM; Scheife RT
    Am J Hosp Pharm; 1977 May; 34(5):531-8. PubMed ID: 326045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dopaminergic Neurotransmission in Parkinson's syndrome (author's transl)].
    Lamprecht F
    Fortschr Neurol Psychiatr Grenzgeb; 1977 Aug; 45(8):459-71. PubMed ID: 198347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Second messengers" in the brain.
    Nathanson JA; Greengard P
    Sci Am; 1977 Aug; 237(2):109-19. PubMed ID: 18797
    [No Abstract]   [Full Text] [Related]  

  • 9. [Extrapyramidal and presenile dementia. Relation between symptoms of dementia and cerebral transmitters, particularly dopamine].
    Kristensen V
    Ugeskr Laeger; 1976 Aug; 138(34):2047-50. PubMed ID: 184570
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopamine and memory function in Parkinson's disease.
    Mohr E; Fabbrini G; Williams J; Schlegel J; Cox C; Fedio P; Chase TN
    Mov Disord; 1989; 4(2):113-20. PubMed ID: 2543918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic mechanisms of opiate actions in brain.
    Eidelberg E; Erspamer R
    J Pharmacol Exp Ther; 1975 Jan; 192(1):50-7. PubMed ID: 164529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic plasticity, dopamine and Parkinson's disease: one step ahead.
    Calabresi P; Mercuri NB; Di Filippo M
    Brain; 2009 Feb; 132(Pt 2):285-7. PubMed ID: 19168452
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemical neurotransmission in the parkinsonian brain.
    Rinne UK; Rinne JO; Rinne JK; Laakso K
    Med Biol; 1987; 65(2-3):75-81. PubMed ID: 2821331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the nigrostriatal dopaminergic neurons in mediating the effect of exogenous L-dopa in Parkinson's disease.
    Melamed E
    Mt Sinai J Med; 1988 Jan; 55(1):35-42. PubMed ID: 3279303
    [No Abstract]   [Full Text] [Related]  

  • 15. Thirty years of dopamine research.
    Carlsson A
    Adv Neurol; 1993; 60():1-10. PubMed ID: 8093570
    [No Abstract]   [Full Text] [Related]  

  • 16. Three types of akinesia in the progressive course of Parkinson's disease.
    Narabayashi H
    Adv Neurol; 1993; 60():18-24. PubMed ID: 8093577
    [No Abstract]   [Full Text] [Related]  

  • 17. Putative neurotransmitters in the brain: selective neuronal uptake, subcellular localization, and interactions with centrally acting drugs.
    Snyder SH
    Biol Psychiatry; 1970 Oct; 2(4):367-89. PubMed ID: 4320227
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathophysiology of motor complications in Parkinson disease: postsynaptic mechanisms are crucial.
    Linazasoro G
    Arch Neurol; 2007 Jan; 64(1):137-40. PubMed ID: 17210824
    [No Abstract]   [Full Text] [Related]  

  • 19. The history of dopamine and levodopa in the treatment of Parkinson's disease.
    Fahn S
    Mov Disord; 2008; 23 Suppl 3():S497-508. PubMed ID: 18781671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Functional morphology of mediator systems of the brain].
    Otellin VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(1):54-8. PubMed ID: 9505409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.